Refine
Has Fulltext
- yes (228)
Is part of the Bibliography
- yes (228)
Year of publication
Document Type
- Journal article (228) (remove)
Language
- English (228) (remove)
Keywords
- Toxikologie (110)
- DNA damage (11)
- Adenosine receptors (8)
- DNA binding (5)
- Genotoxicity (5)
- oxidative stress (5)
- Adenylate cyclase (4)
- DNA (4)
- G proteins (4)
- Pharmakologie (4)
- heart failure (4)
- metabolism (4)
- micronuclei (4)
- Carcinogenesis (3)
- Carcinogenicity (3)
- ERK1/2 (3)
- Enzyme induction (3)
- Micronuclei (3)
- apoptosis (3)
- cytoskeleton (3)
- fluorescence resonance energy transfer (3)
- inflammation (3)
- mycotoxin (3)
- signal transduction (3)
- vitamin B6 (3)
- 1 (2)
- 5-Azacytidine (2)
- A1 adenosine receptors (2)
- Ames test (2)
- Carcinogen (2)
- Carcinogens (2)
- DNA repair (2)
- Diethylstilbestrol (2)
- Dose response (2)
- Dose-response relationship (2)
- Electropermeabilization (2)
- Ernährung (2)
- Estrogen (2)
- G protein-coupled receptors (2)
- G-protein (2)
- GPCR (2)
- Hormone (2)
- Medizin (2)
- N-formyl peptides (2)
- Pharmazie (2)
- RKIP (2)
- Radioligand binding (2)
- Rat (2)
- Reproductive toxicity (2)
- Salmonella/microsome assay (2)
- Silicones (2)
- actin (2)
- actinomycetes (2)
- adenosine receptors (2)
- barbiturates (2)
- biased signaling (2)
- biomedicine, general (2)
- calcium (2)
- cancer (2)
- cancer risk (2)
- cell biology (2)
- comet assay (2)
- cytokinins (2)
- differentiation (2)
- environmental health (2)
- familial DCM (2)
- fluorescence imaging (2)
- heart (2)
- iPSC-cardiomyocytes (2)
- immunohistochemistry (2)
- in-vivo (2)
- insulin (2)
- kidneys (2)
- lymphocytes (2)
- mast cells (2)
- medicine (2)
- membrane skeleton (2)
- meningitis (2)
- nephrotoxicity (2)
- occupational medicine/industrial medicine (2)
- pharmacology/toxicology (2)
- phosphorylation (2)
- pneumolysin (2)
- pyridoxal phosphatase (2)
- rat brain membranes (2)
- risk assessment (2)
- therapy (2)
- transcription factors (2)
- yam (2)
- (Mouse L-cell) (1)
- (Rat brain membrane) (1)
- (Rat liver) (1)
- (Salmonella) (1)
- 18F-FDG (1)
- 2',7'-dichlorofluorescin (1)
- 2-Acetylaminofluorene (1)
- 2-Dichloroethane (1)
- 2-Dioxetane (1)
- 2-Generation reproduction (1)
- 3R (1)
- 4'-hydroxylation (1)
- 4-(p-nitrobenzyl)pyridine (1)
- 6-benzylaminopurine (1)
- 8-Hydroxy-deoxyguanosine (1)
- A(2B) receptors (1)
- A1 (1)
- A1 Adenosine receptors (1)
- A<sub>2</sub> Adenosine receptor (1)
- AMPK (1)
- A\(_{2A}\) adenosine receptor antagonist (1)
- Adenosine receptor (1)
- Adenosine receptor antagonists (1)
- Adenosinrezeptor (1)
- Aflatoxin (1)
- Aflatoxin B1 (1)
- Alkylation (1)
- Alzheimers disease (1)
- Amino acid composition (1)
- Amino acids (1)
- Anabolieagent (1)
- Aniline derivatives (1)
- Anthraquinone glycosides (1)
- Aryl hydrocarbon rnonooxygenase (1)
- Atria (1)
- B cells (1)
- BETA(2)-adrenergic receptor (1)
- Barbiturates (1)
- Barth syndrome (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Benzene (1)
- Benzo(a)pyrene-DNA binding (1)
- Berenil (1)
- Beta(1)-adrenergic receptor (1)
- Beta(2)-adrenergic receptor (1)
- Biomarkers (1)
- Bromodeoxyuridine labeling (1)
- C1q/TNF related protein (CTRP) (1)
- CIB1 (1)
- CRISPR Cas9 (1)
- CRISPR/Cas9 (1)
- CaMKII (1)
- Calcium (1)
- Cancer prevention (1)
- Carcinogen risk Individual susceptibili (1)
- Carcinogenic potency (1)
- Cardiac myocyte ; Beta-Receptor ; Muscarinic receptor ; cAMP ; G-protein ; Serum (1)
- Cell death and comet assay (1)
- Cell transformation (1)
- Chemical carcinogenesis (1)
- Chemotactic receptors (1)
- Choline deficiency (1)
- Chromosome aberration (1)
- Chromosome distribution (1)
- Chronic heart-failure (1)
- Covalent DNA binding (1)
- Covalent binding (1)
- Covalent binding index - Diethylstilbestrol (1)
- Cyclic AMP (1)
- Cytochrome b5 (1)
- DAMGO (1)
- DCM genetic background (1)
- DES (1)
- DNA Binding (1)
- DNA adduct . Repair endonuclease (1)
- DNA binching (1)
- DNA damage response (1)
- DNA metabolism (1)
- DNA methylation (1)
- DNA transfection (1)
- DNS-Schädigung (1)
- Dermatologie (1)
- Dietary process-related contaminants (1)
- Diisononyl phthalate (1)
- Dioscorea (1)
- Drug resistance (1)
- ERK signaling (1)
- Electric Field (1)
- Electrical breakdown (1)
- Electrophiles (1)
- Emodin (1)
- Endogenous genotoxicity (1)
- Epoxide hydrolase (1)
- Estrone (1)
- Ethionine (1)
- Eukaryotic cell (1)
- External exposure assessment (1)
- FCS (1)
- FPG protein (1)
- FRET (1)
- Fabry Disease (FD) (1)
- Fischer 344 rats (1)
- Flow cytometry (1)
- Fluorescence resonance energy transfer (1)
- Friedreich’s ataxia (1)
- G protein coupled receptor (GPCR) (1)
- G protein-coupled receptor (1)
- G-protein coupled receptor (1)
- GABA-receptor complex (1)
- GFAT1 (1)
- GFAT2 (1)
- GFPT1 (1)
- GFPT2 (1)
- GPCRs (1)
- Gastric carcinogenesis (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Gene Transfer (1)
- Gene transfer (1)
- Genetic instability (1)
- Glutathione Stransferase (1)
- HIV infection (1)
- HPLC-MS/MS method (1)
- HeLa cells (1)
- High-throughput screening (1)
- Hoechst 33258 dye (1)
- Human platelets (1)
- Hybridoma (1)
- Immunization (1)
- Immunologie (1)
- In vitro toxicity testing (1)
- Inhalation (1)
- Ischemia/reperfusion (1)
- Jolly bodies (1)
- K + -channels (1)
- Kidneys (1)
- Kinetochore (1)
- Kinetochores (1)
- Krebs (1)
- Krebs <Medizin> (1)
- L5178Y cells (1)
- LTB4 receptor (1)
- Latrophilin (1)
- Leukocyte/endothelium interaction (1)
- Lung (1)
- MMQ cells (1)
- MammaJian mutagenicity test (1)
- Mechanism of action (1)
- Melanocortin 4 receptor (MC4R) (1)
- Melanocyte stimulating hormones MSH (1)
- Metabolism saturation (1)
- Microcirculation (1)
- Micronucleus formation (1)
- Micronucleus test (1)
- Mitosis (1)
- Molekularpharmakologie (1)
- Mutagenicity (1)
- Mutagenicity assay (1)
- Mutagens (1)
- Mutation assay (1)
- Myokarditis (1)
- N-methyl-N-nitrosourea (1)
- N1E 115 cells (1)
- Na\(_V\)1.8 (1)
- Neomycin Resistance (1)
- Nitrosation (1)
- Nitrosierung (1)
- O-GlcNAc (1)
- OXPHOS (1)
- Oxidative stress (1)
- Oxygen radical (1)
- PBPK/PBTK model (1)
- PDE (1)
- PDE2 (1)
- PET (1)
- PKA (1)
- Phosphodiesterase (1)
- Photoaffinity labelling (1)
- Physiologically based kinetic models (1)
- Pointmutation (1)
- Prevalence (1)
- Prognostic impact (1)
- Prolactin (1)
- Protein binding (1)
- Protein coding (1)
- QIVIVE (1)
- Quantitative risk assessment (1)
- RBM20 mutations (1)
- ROS (1)
- Radiation inactivation (1)
- Radicals (1)
- Radioligand binding - 86Rb + -efflux (1)
- Radioligands (1)
- Radioligauds (1)
- Raman micro-spectroscopy (1)
- Rat Iiver microsomes (1)
- Rat liver peroxisome (1)
- Riot control agents (1)
- Risk assessment (1)
- Risk estimation (1)
- Risk-factors (1)
- SCN5a (1)
- ST-elevation myocardial infarction (1)
- Salmonella typhimurium (1)
- Sensitivity (1)
- Short-term tests (1)
- Species differences (1)
- Spontaneous tumours (1)
- Stable Transformation (1)
- Streptomyces (1)
- T cells (1)
- TK6 cells (1)
- Target size (1)
- Theophylline (1)
- Thymidine glycol (1)
- Toxin (1)
- Transfection (1)
- Transgenic mouse (1)
- Transgenie mice (1)
- Trenbolone (1)
- Unscheduled DNA synthesis (1)
- Uterine tumors (1)
- Valvular heart-desease (1)
- Venerologie (1)
- Volume distribution (1)
- Wachstumskonus (1)
- Water resources (1)
- Xanthines (1)
- Zellskelett (1)
- [3H]PIA binding (1)
- absorption (1)
- actin cytoskeleton (1)
- activation (1)
- active zone (1)
- acute slices (1)
- adenine (1)
- adenosine (1)
- adenosine 3',5'-cyclic monophosphate (1)
- adenylate cyclase (1)
- adenylyl cyclase signaling cascade (1)
- adenylyl-cyclase isoforms (1)
- adhesion GPCR (1)
- adiponectin (1)
- adipose tissue (1)
- adult cardiac myocytes (1)
- adverse outcome pathway (1)
- adverse outcome pathway (AOP) (1)
- aflatoxin (1)
- ageing (1)
- agonists (1)
- aldosterone (1)
- alkylation (1)
- allelic variant (1)
- alternative methods (1)
- amine (1)
- amino acid (1)
- antagonists (1)
- anti-Parkinson agents (1)
- anti-inflammatory agents (1)
- antibacterial/antiviral drug (1)
- antibodies (1)
- antibody/autoantibody (1)
- antioxidants (1)
- aortocaval fistula model (1)
- aromatic amides (1)
- arrhythmia (1)
- arrhythmogenesis (1)
- assay (1)
- association (1)
- astrocytes (1)
- atopic eczema (1)
- atrial natriuretic peptide (1)
- avaliação de risco (1)
- bacterial meningitis (1)
- bariatric surgery (1)
- base excision repair (incision activity) (1)
- beta2-adrenoceptor knockout (1)
- beta3 CL 316,243 (1)
- binding (1)
- binding affinity (1)
- bioactive compounds (1)
- biofilms (1)
- biological techniques (1)
- biology (1)
- biomarker of exposure (1)
- biomarkers (1)
- blood coagulation factor XIII (1)
- blood plasma (1)
- blood pressure (1)
- blood samples (1)
- bone marrow (1)
- brain damage (1)
- brain membranes (1)
- cAMP (1)
- calcitonin gene-related peptide (1)
- calmodulin (1)
- carcinogen (1)
- cardiac hypertrophy (1)
- cardiac magnetic resonance imaging (1)
- cardiac myocyte ; muscarinic K current ; G-protein ; Albumin ; serum (1)
- cardiac remodelling (1)
- cardiomyocyte (1)
- cardiomyocytes (1)
- cardiovascular diseases (1)
- caveolin-1 (1)
- cell fate (1)
- cell fusion (1)
- cell proliferation (1)
- cell signalling (1)
- cell staining (1)
- chalcone (1)
- chemotactic receptors (1)
- chemotaxis (1)
- child health (1)
- cholesterol depletion (1)
- cholesterol-dependent cytolysin (1)
- chronic heart failure (1)
- chronic kidney disease (1)
- chronophin (1)
- cisplatin (1)
- classification (1)
- classification and labeling (1)
- clinical genetics (1)
- co-culture (1)
- coated vesicles (1)
- cognitive impairment (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- computational biophysics (1)
- conduction disease (1)
- conformational auto-epitope (1)
- conjugated mycotoxins (1)
- constitutive activity (1)
- contact lens (1)
- continuous (1)
- contractility (1)
- coumarin (1)
- coupled receptor (1)
- covalent binding (1)
- creatinine (1)
- crystal structure (1)
- cyclic AMP (1)
- cyclic dipeptide (1)
- cyclic nucleotides such as cyclic adenosine monophosphate (1)
- cyclic peptides/cyclopeptides (1)
- cyclic-AMP (1)
- cyclic-gmp (1)
- cyclopeptide therapy (1)
- cytochrome P450 2C9 (1)
- cytochrome P450s (1)
- cytome biomarkers (1)
- cytosol (1)
- cytotoxic (1)
- dCIRL (1)
- danio rerio (1)
- definition (1)
- dendritic spines (1)
- desensitization (1)
- detrusor muscle (1)
- developmental biology (1)
- diabetes (1)
- diagnosis (1)
- dialysis (1)
- dicyclohexyl phthalate (1)
- diet (1)
- dilated cardiomyopathy with ataxia (1)
- disrupting chemicals (1)
- disruptor endócrino (1)
- docking (1)
- domains (1)
- dormancy (1)
- down-regulation (1)
- drug (1)
- dunce (1)
- eccentric hypertrophy (1)
- ectodomain cleavage (1)
- efficient intervention points (1)
- endocrine disruptor (1)
- endogenous (1)
- energy-transfer (1)
- environmental phenols (1)
- enzyme-linked immunoassays (1)
- epigenetics (1)
- estrogen receptor (1)
- ethanol (1)
- etoposide (1)
- eugenol (1)
- exposição humana (1)
- exposure (1)
- fatty liver (1)
- fentanyl (1)
- fetal testis (1)
- fluorescence (1)
- fluorescence correlation spectroscopy (1)
- fluorescence detection (1)
- fluorescence recovery after photobleaching (1)
- fluorescent probes (1)
- food contact materials (1)
- food safety (1)
- food security (1)
- formyl peptides (1)
- functional clustering (1)
- fungi (1)
- gastrointestinal cancer (1)
- general medicine (1)
- genetics (1)
- genomic damage (1)
- genotoxic (1)
- genotoxicity (1)
- genotypes (1)
- glucuronide (1)
- glutamate (1)
- glycolytic flux control (1)
- gravidez (1)
- growth cone (1)
- hA<sub>3</sub>AR (1)
- hOCT1 (1)
- haematopoietic stem cells (1)
- haloacid dehalogenase (1)
- haloacid dehalogenase-type phosphatase (1)
- healing and remodelling processes (1)
- hexosamine biosynthesis pathway (1)
- hiPSC-CM (1)
- hidden mycotoxins (1)
- histamine release (1)
- homeostasis (1)
- homodimerization (1)
- hormone receptors (1)
- human (1)
- human A(3) (1)
- human biomonitoring (1)
- human exposure (1)
- human lung (1)
- hypertension (1)
- hypertonic solution (1)
- identification (1)
- image analysis (1)
- impact pharmacogenetics (1)
- in vivo (1)
- indolylpyrimidylpiperazines (1)
- induced pluripotent stem cell cardiomyocytes (1)
- induced pluripotent stem cells (1)
- inflammatory diseases (1)
- insulin signaling (1)
- internalization (1)
- international union (1)
- intracellular loop (1)
- intrinsic metabolism (1)
- ionic look (1)
- ischemic stroke (1)
- isoproterenol (1)
- key event relationship (1)
- kinases (1)
- laminopathy (1)
- lamivudine (1)
- late Na\(^+\) current (I\(_{NaL}\)) (1)
- legislation (1)
- life (1)
- ligand binding (1)
- lipid rafts (1)
- lipidomics (1)
- listeriolysin O (1)
- live imaging (1)
- liver (1)
- liver microsomes (1)
- living vells (1)
- long-read sequencing (1)
- lovastatin (1)
- lysosomal disruption (1)
- lysosomal storage disorders (1)
- mTOR-inhibitor RAD-001 (1)
- maintenance of genomic integrity (1)
- major depression (1)
- male rats (1)
- mammalian genomics (1)
- marine sponges (1)
- masked mycotoxins (1)
- matrix metalloproteinase (1)
- maturation strategies (1)
- mechanotransduction (1)
- membrane (1)
- membrane transporters (1)
- memory B cells (1)
- mercapturic acid (1)
- metabotropic signalling (1)
- micronucleus test (1)
- microvessel permeability (1)
- mild (1)
- mitochondria (1)
- mitochondrial DNA polymerase γ (1)
- mitochondrial cardiomyopathy (1)
- mitotic disturbance (1)
- modelo PBPK/PBTK (1)
- modified mycotoxins (1)
- molecular biology (1)
- molecular dynamics (1)
- molecular modeling (1)
- molecular modelling (1)
- monogenetic cardiomyopathies (1)
- mortality (1)
- motor performance (1)
- mouse lymphoma L5178Y (1)
- mouse models DNA damage (1)
- mucosa (1)
- multivariate data analysis (1)
- mutagen (1)
- mutagenicity (1)
- mutant mice (1)
- mutation triggers (1)
- mycotoxin derivates (1)
- mycotoxin metabolites (1)
- mycotoxins (1)
- myocarditis (1)
- n-hexyl phthalate (1)
- nanopore (1)
- natural (1)
- neocortex (1)
- neurodegenerative diseases (1)
- neuronal dendrites (1)
- neurons (1)
- neuropsychiatric diseases (1)
- neurotransmitter biosynthesis (1)
- neutrophils (1)
- nitric-oxide (1)
- nitrosation (1)
- nitroso compound (1)
- no (1)
- nutritional composition (1)
- o-Chlorobenzylidene malononitrile (1)
- obesity (1)
- occurrence (1)
- ochratoxin A (1)
- octopamine (1)
- opioid ligands (1)
- optimal drug combination (1)
- optimal drug targeting (1)
- optimal pharmacological modulation (1)
- optimal treatment strategies (1)
- organ toxicity (1)
- parathyroid hormone 1 receptor (1)
- partial agonists (1)
- performance liquid-chromatography (1)
- peripheral nerve (1)
- peripheral-blood lymphocytes (1)
- personalized treatment (1)
- perspectives (1)
- pharmacogenetics (1)
- phosphoglycolate phosphatase (1)
- phosphoinositides (1)
- photoaffinity labelling (1)
- plasma membrane (1)
- poly(ADP-ribosyl)ation (1)
- pore formation (1)
- pore-forming toxin (1)
- positron emission tomography (1)
- potent (1)
- pregnancy (1)
- primary aromatic amine (1)
- protein (1)
- protein alkylation (1)
- protein design (1)
- protein-coupled receptors (1)
- protein-coupled-receptors (1)
- psoriasis (1)
- psychiatric disorders (1)
- purine derivatives (1)
- pyrrolizidine alkaloids (1)
- quantitative assessments (1)
- radiation (1)
- radii (1)
- radioligand (1)
- radioligand binding (1)
- rat pheochromocytoma cells (1)
- receptor binding (1)
- receptor pharmacology (1)
- receptor solubilization (1)
- receptor-G protein coupling (1)
- receptor-G protein coupling. (1)
- receptors (1)
- regulation (1)
- relaxation (1)
- reproductive and developmental toxicity (1)
- resveratrol (1)
- risk-assesment (1)
- sensory physiology (1)
- serum (1)
- sex (1)
- sexual development (1)
- signaling microdomain (1)
- simulated digestion (1)
- single-molecule microscopy (1)
- solid-phase extraction (1)
- solubilization (1)
- splenic function (1)
- sponges (1)
- spontaneously hypersensitive-rats (1)
- staphilococci (1)
- statins (1)
- stomach (1)
- streptomyces (1)
- sub-Saharan Africa (1)
- subtypes (1)
- sugars (1)
- synapses (1)
- synaptic plasticity (1)
- tMCAO (1)
- tandem mass-spectrometry (1)
- targets (1)
- testosterone production (1)
- therapeutic potential (1)
- thyroid hormone (1)
- tissue (1)
- tolbutamide substrate (1)
- toxicocinética (1)
- toxicokinetics (1)
- toxicology (1)
- trans-Golgi network (1)
- transgenic animals (1)
- triazolotriazine derivatives (1)
- tuber (1)
- ultrastructure (1)
- urea (1)
- uremic toxins (1)
- variocosities (1)
- vitamin-D-receptor (1)
- volume overload (1)
- warfarin polymorphisms (1)
- weight of evidence (1)
- yellow fluorescent protein (1)
- µ-Opioid receptor (1)
- β-adrenergic receptors (1)
- β1-adrenoceptor/β1-adrenergic receptor (1)
- βAR (1)
- γ-Aminobutyric acid (GABA) (1)
Institute
- Institut für Pharmakologie und Toxikologie (228) (remove)
Sonstige beteiligte Institutionen
The structure of monensin, C36H620 11 , has been deterrnined by X-ray analysis of its crystalline monohydrate (orthorhombic, a = 15.15, b = 23.61, c = 10.65 A, Z = 4, space group P212121). Phases were assigned by direct methods, malring use of the 'tangent formula'. Although the conformation of the free acid resembles that of the silver salt in being cyclic, there are differences in the hydrogen bonding pattern. These featurcs are discussed in relation to the cornplexation of metal ions by m.onensin.
The thermodynainic parameters ΔH0, ΔG0 and ΔS0 - and thereby the equilibrium constants - for the complexation of the carrier antibiotics nigericin and monensin with sodium and potassium ions in methanol at 25°C have been determined by microcalorimetry. Tbc results are discussed in terms of the nature of the interaction between ligands and cations.
The lnfluence of mlcrosomal and nuclear aryl hydrocarbon hydroxylase (AHH) actlvlty on the covalent blndlng of [G·3H]benzo(a )pyrene to rat llver DNA was evaluated in viWJ. lnductlon of mlcrosomal AHH was obtalned alter phenobarbltal treatment (160% of control), whlch also lncreased DNA blndlng to 190%, but left the nuclear actlvlty unchanged. Nuclear AHH was lnduced wlth dleldrln (150%), and the blndlng was decreased to 75%, whereaa the mlcrosomal AHH was at control Ievei. The lncreaslng effect of mlcrosomal AHH lnductlon as weil as the decreaslng effect of nuclear AHH lnductlon on the blndlng was shown clearly when the data of the Individual rata were uaed to solve the equatlon Binding = e•(mlcroeomal AHH) + b•(nuclear AHH) + c Multiple linear regresslon analysls wlth the data from 10 anlmala reaulted ln positive valuea for a and c, a negative value for b, and a good multiple correlatlon coefflclent of r = 0.974. Pretreatment wlth 3-methylcholanthrene ln· duced mlcrosomal AHH to 380% of control and nuclear AHH to 590% and lncreased the blndlng' to 175,.-o. The blndlng was hlgher than predlcted by the formula found, probably because the lncreaslng lnfluence of lnduced mlcrosomal AHH overahadowed the decreaslng effect of the nuclear AHH. The study ahows clearly that the blndlng of a forelgn compound to DNA in viWJ Ia dependent not only on mlcrosomal enzyme actlvltles but also on nuclear actlvltles even lf the latter are conslderably lower than thoae of mlcrosomes.
Thecovalent bindingof [6,7-\(^3\)H]ethinylestradiol (EE)and [6,7-\(^3\)H]estrone (E) to liver DNA of 200 g female ratswas measured 8 h after the administration of 80 \(\mu\)g (9.2 mCi) estrogen by gavage. The binding is 1.5 for EE and 1.1 for E, expressedas binding to DNA/dose, in units of \(\mu\)mol hormonefmol DNA phosphate/mmole honnone/kg body wt. It is in the same order of magnitude as for benzene and about 10 000 tim es below the binding of typical liver carcinogens, such as aflatoxin B\(_1\) or N,N-dimethylnitrosamine.
Wlth radioactive compound of high specific activity, the binding of carcinogene to DNA can be measured wlth doses that are ineffective ln long-term studies. The binding of tritiated benzo(a )pyrene to liver DNA of adult male rats has been determined 50 hr after a singie l.p. injection of doses between 40 1'9/kg and 4 mg/kg. The doseresponse relationship is linear up to 1 mg/kg, shows a step towards 2 mg/kg, and gives a shallow linear slope above that value. The observed binding ranges from 1.7 to 180 nmoles benzo(a)pyrene per mole DNA phosphate. The nonlinearity could be due to an induction of metabolizing enzymes. The microsomal aryl hydrocarbon hydroxylase activity increases significantly 24 hr after a single dose of 4 mg/kg and 48 hr after doses of 2 and 4 mg/kg, but no induction Ia found with 1 mg/kg. The binding from an equimolar dose is 35 times lower than the one found on mouse skin DNA and 300 times lower than that of N,Ndlmethylnitrosamine in rat liver. A good correlatlon exiats to the respective tumor formation in long-term studles.
Aryl hydrocarbon hydroxylase (AHH) has been measured in male rat Jiver nucJei and microsomes after treatment of adult animals with various inducers for up to 14 days. After daily i.p. injections of 3-methylcholanthrene (MC, 20 mg/kg) the nuclear activity increased to a maximum of 600 per cent of the control activity after 4 days whereas the microsomal activity was 400 per cent of control at the same date. After 12 days, both activities equilibrated at 400 per cent. A similar time course was found after a single i.p. injection of 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD, 0.01 mg/kg) with an induction to .500 and 300 per cent for nuclei and microsomes, respectiveJy. after 2 days, and to 400 per cent for both after 12 days. PhenobarbitaJ (PB) was given continuously in the drinking water (I g/1) and induced the microsomal activity to 200 per cent after 8 days and 170 per cent after 14 days. The nuclear activity was only slightly induced to a constant Ievei of 130 per cent between day 8 and 14. Dieldrin did not significantly increase the microsomal activity after daiJy i.p. injections (20 mg/kg), but the nuclear activity raised to 200 per cent after 3 days and levelled down tocontrol valuesafter 12 days. Other inducers tested were benz[a)anthracene (BA), hexachlorobenzene (HCB} and 1,1.1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT). The induction pattern with BA was similar tothat of MC, a modeJ compound for the group of cytochrome P448 inducers. The induction by HCB and DDT resembled that by PB. a typical cytochrome P450 inducer.
In the inhalation system described an animal can be kept in the same atmosphere of a 2-liter desiccator for up to 24 h. The expired carbon dioxide is adsorbed with soda lime and the resulting reduced pressure is balanced by a supply of oxygen also used for the inflow of the chemical to be investigated. Urine and faeces can be collected ~eparately and the system allows a periodical control of the concentration of the chemical by sampling the air with needle and syringe.